Literature DB >> 20697346

MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.

M P Ponnusamy1, I Lakshmanan, M Jain, S Das, S Chakraborty, P Dey, S K Batra.   

Abstract

The acquisition of invasiveness in ovarian cancer (OC) is accompanied by the process of epithelial-to-mesenchymal transition (EMT). The MUC4 mucin is overexpressed in ovarian tumors and has a role in the invasiveness of OC cells. The present study was aimed at evaluating the potential involvement of MUC4 in the metastasis of OC cells by inducing EMT. Ectopic overexpression of MUC4 in OC cells (SKOV3-MUC4) resulted in morphological alterations along with a decreased expression of epithelial markers (E-cadherin and cytokeratin (CK)-18) and an increased expression of mesenchymal markers (N-cadherin and vimentin) compared with the control cells (SKOV3-vector). Also, pro-EMT transcription factors TWIST1, TWIST2 and SNAIL showed an upregulation in SKOV3-MUC4 cells. We further investigated the pathways upstream of N-cadherin, such as focal adhesion kinase (FAK), MKK7, JNK1/2 and c-Jun, which were also activated in the SKOV3-MUC4 cells compared with SKOV3-vector cells. Inhibition of phospho-FAK (pFAK) and pJNK1/2 decreased N-cadherin expression in the MUC4-overexpressing cells, which further led to a significant decrease in cellular motility. Knockdown of N-cadherin decreased the activation of extracellular signal-regulated kinase-1/2 (ERK1/2), AKT and matrix metalloproteinase 9 (MMP9), and inhibited the motility in the SKOV3-MUC4 cells. Upon in vivo tumorigenesis and metastasis analysis, the SKOV3-MUC4 cells produced significantly larger tumors and demonstrated a higher incidence of metastasis to distance organs (peritoneal wall, colon, intestine, stomach, lymph nodes, liver and diaphragm). Taken together, our study reveals a novel role for MUC4 in inducing EMT through the upregulation of N-cadherin and promoting metastasis of OC cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697346      PMCID: PMC3005772          DOI: 10.1038/onc.2010.309

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.

Authors:  Kimita Suyama; Irina Shapiro; Mitchell Guttman; Rachel B Hazan
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

Review 3.  Mucins in cancer: protection and control of the cell surface.

Authors:  Michael A Hollingsworth; Benjamin J Swanson
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

4.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

Authors:  M Andrianifahanana; N Moniaux; B M Schmied; J Ringel; H Friess; M A Hollingsworth; M W Büchler; J P Aubert; S K Batra
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

5.  MUC4 expression is increased in dysplastic cervical disorders.

Authors:  A López-Ferrer; F Alameda; C Barranco; M Garrido; C de Bolós
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

6.  Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells.

Authors:  Stéphanie Truant; Erik Bruyneel; Valérie Gouyer; Olivier De Wever; François-René Pruvot; Mark Mareel; Guillemette Huet
Journal:  Int J Cancer       Date:  2003-05-10       Impact factor: 7.396

Review 7.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

8.  Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.

Authors:  Nicolas Moniaux; Grish Chandra Varshney; Subhash Chand Chauhan; Marie Christine Copin; Maneesh Jain; Uwe A Wittel; Mahefatiana Andrianifahanana; Jean-Pierre Aubert; Surinder Kumar Batra
Journal:  J Histochem Cytochem       Date:  2004-02       Impact factor: 2.479

9.  Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

Authors:  Ajay P Singh; Nicolas Moniaux; Subhash C Chauhan; Jane L Meza; Surinder K Batra
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

Review 10.  Cadherin switch in tumor progression.

Authors:  Rachel B Hazan; Rui Qiao; Rinat Keren; Ines Badano; Kimita Suyama
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

View more
  63 in total

1.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

2.  ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics.

Authors:  Dan Su; Dionyssios Katsaros; Shenhua Xu; Haiyan Xu; Yun Gao; Nicoletta Biglia; Jianguo Feng; Lisha Ying; Ping Zhang; Chiara Benedetto; Herbert Yu
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  High expression of TGF-β1 in the vaginal incisional margin predicts poor prognosis in patients with stage Ib-IIa cervical squamous cell carcinoma.

Authors:  Dong-Mei Fan; Xin-Jun Wang; Tao He; Yan Wang; Dan Zhou; Guo-Qiang Kong; Tao Jiang; Mei-Mei Zhang
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

Review 4.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

5.  Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2.

Authors:  Ji-Min Seo; Sooyoung Park; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

6.  Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer.

Authors:  D I Wu; Lei Liu; Chengcheng Ren; Dan Kong; Pengqi Zhang; Xiaoming Jin; Tianzhen Wang; Guangmei Zhang
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

7.  Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology.

Authors:  Ho Seok Seo; Jiyeon Hyeon; In Hye Song; Han Hong Lee
Journal:  J Mol Histol       Date:  2020-04-02       Impact factor: 2.611

8.  Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

Authors:  Neeley Remmers; Judy M Anderson; Erin M Linde; Dominick J DiMaio; Audrey J Lazenby; Hans H Wandall; Ulla Mandel; Henrik Clausen; Fang Yu; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

9.  Analysis of tumor-associated mucin glycotopes by Western transfer methods.

Authors:  Vinayaga S Gnanapragassam; Maneesh Jain; Surinder K Batra
Journal:  Methods Mol Biol       Date:  2013

10.  Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.

Authors:  S Das; S Rachagani; Y Sheinin; L M Smith; C B Gurumurthy; H K Roy; S K Batra
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.